New scan could spot hidden cancer activity
NCT ID NCT05226663
Summary
This study is testing whether a new radioactive imaging agent, called [18F]FluorThanatrace, can improve PET/CT scans for breast cancer. The goal is to see if this tracer can better detect an enzyme linked to cancer growth. The trial involves 36 adults with breast cancer who are scheduled for a biopsy or surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Siteman Cancer Center at Washington University
St Louis, Missouri, 63110, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.